Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yubin Ge

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Nanomedicine (London, England)|January 7, 2025
Enhanced safety and efficacy profile of CD40 antibody upon encapsulation in pHe-triggered membrane-adhesive nanoliposomesSalma Althobaiti, Prahlad Parajuli, Duy Luong, et al.
Biochemical Pharmacology|December 7, 2017
Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivoYongwei Su, Xinyu Li, Jun Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupYubin Ge, Christina L Haska, Katherine LaFiura, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cellsDaniel A Luedtke, Xiaojia Niu, Yihang Pan, et al.
Cancer Research|January 28, 2004
The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell linesYubin Ge, Tanya L Jensen, Mark L Stout, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 9, 2022
c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemiaShuang Liu, Xinan Qiao, Shuangshuang Wu, et al.
Biomolecules|February 26, 2025
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future ProspectsMohamad Bakkar, Sara Khalil, Komal Bhayekar, et al.
Leukemia Research|July 5, 2024
Combining the novel FLT3 and MERTK dual inhibitor MRX-2843 with venetoclax results in promising antileukemic activity against FLT3-ITD AMLShuangshuang Wu, Fangbing Liu, Yuqing Gai, et al.
Cells|January 28, 2026
Enhancing the Nucleoside Analog Response with Translational Therapeutic Approaches to Overcome ResistanceJenna Thibodeau, Kian Hershberger, Sai Samanvitha M Ramakrishna, et al.
Journal of Medicinal Chemistry|August 10, 2016
Synthesis and Antileukemic Activities of Piperlongumine and HDAC Inhibitor Hybrids against Acute Myeloid Leukemia CellsYi Liao, Xiaojia Niu, Bailing Chen, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Nanomedicine (London, England)|January 7, 2025
Enhanced safety and efficacy profile of CD40 antibody upon encapsulation in pHe-triggered membrane-adhesive nanoliposomesSalma Althobaiti, Prahlad Parajuli, Duy Luong, et al.
Biochemical Pharmacology|December 7, 2017
Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivoYongwei Su, Xinyu Li, Jun Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupYubin Ge, Christina L Haska, Katherine LaFiura, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cellsDaniel A Luedtke, Xiaojia Niu, Yihang Pan, et al.
Cancer Research|January 28, 2004
The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell linesYubin Ge, Tanya L Jensen, Mark L Stout, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 9, 2022
c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemiaShuang Liu, Xinan Qiao, Shuangshuang Wu, et al.
Biomolecules|February 26, 2025
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future ProspectsMohamad Bakkar, Sara Khalil, Komal Bhayekar, et al.
Leukemia Research|July 5, 2024
Combining the novel FLT3 and MERTK dual inhibitor MRX-2843 with venetoclax results in promising antileukemic activity against FLT3-ITD AMLShuangshuang Wu, Fangbing Liu, Yuqing Gai, et al.
Cells|January 28, 2026
Enhancing the Nucleoside Analog Response with Translational Therapeutic Approaches to Overcome ResistanceJenna Thibodeau, Kian Hershberger, Sai Samanvitha M Ramakrishna, et al.
Journal of Medicinal Chemistry|August 10, 2016
Synthesis and Antileukemic Activities of Piperlongumine and HDAC Inhibitor Hybrids against Acute Myeloid Leukemia CellsYi Liao, Xiaojia Niu, Bailing Chen, et al.
Pageof 14